Literature DB >> 10339973

[High inducibility of Epstein-Barr virus replication in B lymphocytes in Vogt-Koyanagi-Harada disease].

H Minoda1, J Sakai, M Sugiura, S Imai, T Osato, M Usui.   

Abstract

PURPOSE: The role of Epstein-Barr virus (EBV) reactivation in the pathogenesis of Vogt-Koyanagi-Harada (VKH) disease was examined.
MATERIAL AND METHODS: Using B lymphocytes obtained from 8 patients with VKH disease and 10 patients with other types of uveitis, immortarized lymphoblast lines were established and infected with EBV. The degree of EBV activation in each lymphoblast line, in the presence and absence of various stimuli, was assessed by measuring the expression of 3 different antigens involved in replication by immunofluorescent staining and western blot analysis. Quantification of EBV DNA in cell culture supernatants was done by polymerase chain reaction. RESULT: Cell lines established from VKH patients expressed more viral antigens that those established from patients with other types of uveitis. There were greater amounts of EBV DNA in the VKH cell lines.
CONCLUSION: B lymphocytes from VKH patients may be more susceptible to EBV activation, and the reactivation of EBV may be involved in the pathogenesis of VKH.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10339973

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  4 in total

1.  Probable Vogt-Koyanagi-Harada Disease after COVID-19 Vaccination: Case Report and Literature Review.

Authors:  Xinyi Ding; Qing Chang
Journal:  Vaccines (Basel)       Date:  2022-05-16

2.  KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease.

Authors:  Ralph D Levinson; Madeline Yung; Akira Meguro; Elham Ashouri; Fei Yu; Nobuhisa Mizuki; Shigeaki Ohno; Raja Rajalingam
Journal:  PLoS One       Date:  2016-08-04       Impact factor: 3.240

3.  Unusual neurologic manifestations of Vogt-Koyanagi-Harada disease: a systematic literature review.

Authors:  Moussa Toudou-Daouda; Abdoul Kadir Ibrahim-Mamadou
Journal:  BMC Neurol       Date:  2022-02-04       Impact factor: 2.474

4.  Vogt-Koyanagi-Harada disease: a retrospective and multicentric study of 41 patients.

Authors:  K Diallo; S Revuz; G Clavel-Refregiers; T Sené; C Titah; M Gerfaud-Valentin; P Seve; R Jaussaud
Journal:  BMC Ophthalmol       Date:  2020-10-07       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.